Sarepta Therapeutics Inc. ( SRPT ) stock is trading higher on Wednesday, with apparently no news to justify the movement.

This week, Sarepta will present data from its gene therapy, delandistrogene moxeparvovec, for Duchenne muscular dystrophy (DMD).

Sarepta presentations will include results from several studies in the delandistrogene moxeparvovec clinical development program and a real-world evidence study of pulmonary function in advanced-stage patients with Duchenne muscular dystrophy treated with casimersen.

In addition to studies to be presented by Sarepta, multiple independent studies on delandistrogene moxeparvovec will be presented, including an abstract on the exploratory use of sirolimus prophylaxis to help mitigate the potential for acute liver injury in patients receiving delandistrogene moxeparvovec.

Also Read: Vinay Prasad’s Comeback To FDA Sparks Debate Over Regulatory Direction

Further, Sarepta will present results from the EMERGENE phase 3 study on the expression of SGCB and safety following bidridistrogene xeboparvovec treatment in patients with LGMD2E/R4.

Earlier in July, the FDA requested that Sarepta halt shipments of the drug after a reported death in a young patient in Brazil.

Just one day before Prasad's departure, the agency unexpectedly reversed its decision and allowed Sarepta to resume shipments for certain patients.

How To Buy Sarepta Stock

By now, you're likely curious about how to participate in the market for Sarepta Therapeutics ( SRPT ) – be it to purchase shares or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

As of publishing time, Sarepta Therapeutics ( SRPT ) is trading at $23.12, and $100 would buy you approximately 4.33 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource.

Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading – either way, it allows you to profit from the share price decline.

Price Action: SRPT stock is up 4.67% at $24.20 during the premarket session at the last check on Wednesday.

Read Next:

Why Rocket Lab’s Latest Launch Deal Has Investors Reaching For The Stars